ArticleScientific reports2026
Transcriptomic and genomic analysis of successful Ethiopian Mycobacterium tuberculosis sub-lineage 4.2.2.2 reveals differential expression of DosR-regulated genes.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Mycobacterium tuberculosis (Mtb) sub-lineage 4.2.2.2 is the most frequently isolated strain of Mtb from Ethiopian treatment-refractory tuberculosis patients. This study investigated the underlying molecular background to Mtb sub-lineage 4.2.2.2 through transcriptomic and genomic analyses. Comparative whole genome sequencing and transcriptomics (RNAseq) was performed with other circulating clinical Ethiopian lineages and sub-lineages: lineage 7, lineage 3, lineage 4 sub-lineage 4.1.2.1, and sub-lineage 4.6.3. We identified seven genes differentially expressed in sub-lineage 4.2.2.2 compared to other Mtb lineages. Of these, six (Rv0331, Rv0720, Rv1993c, Rv2030c, Rv2034 and Rv3129) were upregulated, while Rv0997a was downregulated. These differentially expressed genes are associated with lipid metabolism, stress responses, protein synthesis and metal transport, suggesting that sub-lineage 4.2.2.2 may be better able to adapt to the complex host-pathogen interactions of infection and transmission. Interestingly, this observation is mirrored by mild induction of DosR-regulated genes in sub-lineage 4.2.2.2 compared to other lineages in vitro, suggesting that enhanced expression of the DosR regulon may influence this sub-lineage’s ability to cause disease in Ethiopia. Taken together, our findings reveal genes that might impact the pathogenicity of Mtb clinical isolates in Ethiopia and identifies single nucleotide polymorphisms that could influence their expression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.